Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
miércoles, octubre 07
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Alvotech
ALVO
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$6.14
0.03
0.49%
Últ. Act.: Oct 6, 7:00 PM
$6.14
0.0301
0.49%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Comparar
Informe de acciones
Privacy Manager
PRO
¿Por qué se mueve?:
Alvotech shares are trading higher after the company announced FDA approval...
Alvotech Financials
Alvotech (ALVO) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Alvotech Q2 EPS $(0.17) Misses $(0.04) Estimate, Sales $106.000M Miss $111.010M Estimate
Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.04) by 325 percent. This is a 221.43 percent decrease over earnings of $0.14 per share from the
Benzinga Newsdesk
PRO
Alvotech Affirms FY2026 Sales Guidance of $650.000M-$700.000M vs $644.838M Est
Alvotech (NASDAQ:ALVO) affirms FY2026 sales outlook from $650.000 million-$700.000 million to $650.000 million-$700.000 million vs $644.838 million estimate.
Benzinga Newsdesk
Earnings Scheduled For May 6, 2026
Benzinga Insights
PRO
Alvotech Q1 Sales $105.900M Miss $140.847M Estimate
Alvotech (NASDAQ:ALVO) reported quarterly sales of $105.900 million which missed the analyst consensus estimate of $140.847 million by 24.81 percent. This is a 20.26 percent decrease over sales of $132.800 million the
Benzinga Newsdesk
PRO
Alvotech Q4 Sales $173.200M Beat $159.927M Estimate
Alvotech (NASDAQ:ALVO) reported quarterly sales of $173.200 million which beat the analyst consensus estimate of $159.927 million by 8.30 percent. This is a 12.95 percent increase over sales of $153.340 million the same
Benzinga Newsdesk
Earnings Scheduled For March 18, 2026
Benzinga Insights
